How Long Do TMS Results Last? A Vermont Guide to Follow-Up Care

How Long Do TMS Results Last? A Vermont Guide to Follow-Up Care

Transcranial magnetic stimulation (TMS) is a non-invasive treatment most commonly used for major depressive disorder. A standard course often involves about 36 weekday sessions over six to nine weeks, although individual treatment plans can differ.

One of the most important questions after treatment is whether the benefit will last. There is no single answer. Some people continue to feel well for a long period after completing TMS, while others notice symptoms returning and may need further support. Follow-up care is therefore an important part of planning treatment, not something to consider only if depression comes back.

For people in Vermont, it can help to discuss a follow-up plan with the treating clinician before the initial course finishes. This should include how progress will be monitored, what changes to look out for, and what options may be available if symptoms return.

What does a lasting TMS response mean?

TMS outcomes are often described using two related terms:

• Response means that depressive symptoms have improved meaningfully.
• Remission means that symptoms have reduced to a minimal level or are no longer causing significant difficulty.

A person may have a response without being in full remission. They may feel more able to get through the day, sleep more regularly, return to work or reconnect with family, while still having some symptoms to manage. Others may reach remission but still need ongoing care to help protect their wellbeing.

TMS is not generally viewed as a permanent cure for depression. Depression can be recurrent, and its course can be affected by life events, physical health, sleep, substance use, stress, medication changes and other mental health conditions. A benefit from TMS can be durable, but it is sensible to make a plan for the possibility that symptoms could return.

Why results vary from person to person

The length of benefit after TMS differs considerably between individuals. It may depend on factors such as:

• how severe or longstanding depression was before treatment;
• whether the person reached response or remission;
• previous patterns of relapse;
• medication and talking-therapy plans;
• ongoing stressors and support at home or work;
• sleep, alcohol or drug use, and physical health;
• whether there are co-occurring conditions, such as anxiety.

TMS was cleared by the US Food and Drug Administration for major depressive disorder in 2008, and for depression with comorbid anxiety in 2021. However, FDA clearance does not mean that every person will have the same result or need the same follow-up.

The most useful measure is usually the person’s own pattern over time. A clinician may use symptom questionnaires alongside conversations about mood, functioning, motivation, sleep and safety. These check-ins can identify early changes before symptoms become more severe.

Relapse does not mean treatment failed

If depression returns after a period of improvement, it is often called a relapse or recurrence. This can feel discouraging, especially after the commitment involved in a full TMS course. It does not necessarily mean that TMS did not work.

A previous positive response may still be useful information when deciding what to do next. The treating team may consider whether symptoms are returning gradually or suddenly, whether there has been a change in medication or circumstances, and whether another form of support is needed.

Contact a clinician promptly if you notice warning signs such as:

• low mood becoming more persistent;
• loss of interest in usual activities;
• changes in sleep, appetite or energy;
• increasing isolation;
• difficulty keeping up with work, study or caring responsibilities;
• thoughts of self-harm or suicide.

If there is an immediate risk of harm, seek urgent help through emergency services or a crisis service rather than waiting for a routine TMS appointment.

Maintenance TMS: what it is and when it may be considered

Maintenance TMS means planned sessions after the initial acute course has ended. The aim is to support ongoing wellbeing and potentially reduce the chance of symptoms returning.

There is not one standard maintenance schedule that suits everyone. Some people do not have maintenance sessions and instead attend clinical reviews. Others may discuss occasional sessions, a short series of sessions at particular intervals, or a plan that is adjusted according to symptoms.

Whether maintenance TMS is appropriate can depend on a person’s treatment history, the degree of improvement, previous relapses and practical considerations. It is worth asking the clinician:

• What follow-up do you recommend after my final session?
• Would maintenance TMS be appropriate in my situation?
• How will we decide if I need further sessions?
• Who should I contact if my symptoms begin to return?
• How would medication or therapy fit with the TMS plan?

Maintenance care is usually only one element of relapse prevention. A plan may also include medication management with a prescribing clinician, psychotherapy, regular sleep, manageable routines, social support and attention to early warning signs.

Re-treatment after symptoms return

Re-treatment, sometimes called a repeat course, means returning for another course of TMS after a previous course has ended and symptoms have returned or worsened.

A repeat course is different from routine maintenance. It is generally considered when there is a clearer return of depression, rather than simply a planned ongoing session. The exact approach can vary. A clinician will normally reassess symptoms, treatment history, current medications and any changes in health before recommending next steps.

If TMS helped previously, tell the new or current treating clinician what changed during the first course. Useful details include when improvement began, which symptoms improved first, whether side effects were manageable, and how long the benefit continued. Common TMS side effects include scalp discomfort and headache. Seizure is a rare risk, and medical screening remains important for each course of treatment.

Do not stop prescribed medication or alter doses without discussing it with the clinician who prescribes it. Similarly, do not assume that a repeat course will be automatically covered by insurance. Coverage criteria and prior authorisation requirements can differ between plans.

Planning follow-up before treatment ends

A clear written follow-up plan can make it easier to act early if mood changes. Before the last few sessions, ask for a review of what happens next.

A practical plan might cover:

• Clinical follow-up: when you will next speak with the TMS provider, psychiatrist, GP or other mental health professional.
• Medication: who is responsible for prescriptions and how medication changes will be managed.
• Therapy and support: whether ongoing counselling, peer support or family involvement would be helpful.
• Monitoring: the symptoms or changes in routine that may signal a decline in mood.
• Contact details: who to call during office hours and what to do outside those hours.
• Crisis planning: what steps to take if you develop suicidal thoughts or feel unable to stay safe.
• Practical access: travel, work arrangements and childcare if further appointments become necessary.

It can also be helpful to involve someone you trust, if you are comfortable doing so. A partner, relative or friend may notice changes in sleep, withdrawal or mood before you do.

Insurance and practical questions in Vermont

Insurance arrangements can influence the timing and structure of follow-up care. In Vermont, people seeking TMS may commonly encounter Blue Cross and Blue Shield of Vermont, MVP Health Care, Cigna, Aetna and Vermont Medicaid, also known as Green Mountain Care.

Your individual cover may depend on the specific plan, diagnosis, previous treatments, provider network and authorisation requirements. Ask both the clinic and insurer about initial treatment, maintenance sessions and possible re-treatment. It is useful to ask what documentation is needed, whether a new assessment is required, and what costs may remain your responsibility.

TMS Therapy Vermont currently lists six published clinics, with directory listings in Colchester, South Burlington, Montpelier, Brattleboro, Bradford and St. Albans. Availability, referral processes and follow-up arrangements may differ by provider, so confirm these details directly with the clinic.

Getting help in Vermont

Use the TMS Therapy Vermont clinic listings to find providers in Colchester, South Burlington, Montpelier, Brattleboro, Bradford and St. Albans. The directory’s insurance guide may help you prepare questions for your plan, and the contact page can help you get in touch with the directory team.

This is educational information, not medical advice.